|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vaccination of patients with small-cell lung cancer with Synthetic Fucosy1 GM-1 conjugated to Keyhole Limpet Hemocyanin显示文摘 | Krug LM Ragupathi G Hood C | 2004 | Clinical Cancer Res2004，10，： | 1 |
| 2 | Immunization with N-propionyl polysialie acid-KLH conjugate in patients with small cell lung Cancer is safe and induces IgM antibodies reactive with SCLC cells amt bactericidal against group B meningocoeci 显示文摘 | Krug LM Ragupathi G Hood C | 2012 | Cancer hnmunol hnmunother2012，61，1： | 1 |
| 3 | Selection of GM2,fueosyl GMI,globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy 显示文摘 | Livingston PO Hood C Krug LM | 2005 | Cancer hnmunol hnmunother2005，54，10： | 1 |
| 4 | Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-I conjugated to keyhole limpet hemoeyanin 显示文摘 | Krug LM Ragupathi G Hood C | 2004 | Clin Cancer Res2004，10，181： | 1 |
| 5 | Selection of GM2,fucosyl GM1,globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy显示文摘 | Livingston PO Hood C Krug LM | 2005 | Cancer Immunother2005，54，10： | 1 |
| 6 | Risk of rupture of postangiographic femoral dales aneurysm显示文摘 | Graham ANJ Wilson CM Hood LM | 1992 | Br J Surg1992，79，： | 1 |
| 7 | Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets small cell lung cancers for antibody mediated immunotherapy显示文摘 | Livingston PO Hood C Krug LM | 2005 | Cancer Immunol Immunother2005，54，10： | 1 |
| 8 | Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin 显示文摘 | Krug LM Ragupathi G Hood C | 2004 | Clin Cancer Res2004，10，181： | 1 |
| 9 | Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci 显示文摘 | Krug LM Ragupathi G Hood C | 2012 | Cancer Immunol Immunother2012，61，1： | 1 |
| 10 | Peloruside A, a novel antimitotic agent with paclitaxel - like microtubule- stabilizing activity显示文摘 | Hood KA West LM Rouwe B | 2002 | Cancer Res2002，62，12： | 1 |
| 11 | Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin 显示文摘 | Krug LM Ragupathi G Hood C | 2004 | Clin Cancer Res2004，10，： | 1 |
| 12 | Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy 显示文摘 | Livingston PO Hood C Krug LM | 2005 | Cancer Immunol Im- munothe2005，54，： | 1 |
| 13 | Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin 显示文摘 | Krug LM Ragupathi G Hood C | 2004 | Clin Cancer Res2004，10，： | 1 |
| 14 | Bosentan and warfarin interaction 显示文摘 | Murphey LM Hood EH | 2003 | Ann Pharmacother2003，37，78： | 1 |
| 15 | Peloruside A,a novel antimitotic agent with paclitaxel -like microtubule-stabilizing activity显示文摘 | Hood KA West LM Rouwe B | | 0，，： | 1 |
| 16 | Risk of rupture of postangiographic femoral false aneurysm显示文摘 | Wilson CM Hood LM | 1992 | Br J Surg1992，79，： | 1 |
| 17 | Depressive symptoms predictchange in glycemic control in adolescents with type 1 diabetes: rates, magnitude, and moderators of change 显示文摘 | Hood KK Rausch JR Dolan LM | 2011 | Pediatr Diabetes2011，12，8： | 1 |
| 18 | Selection of GM2,fucosyl GM1,globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy显示文摘 | Livingston PO Hood C Krug LM | 2005 | Cancer Immunol Immunother2005，54，10： | 1 |
| 19 | Peloruside A, a novel antimitotie agent with paelitaxel-like microtubule- stabilizing activity显示文摘 | Hood KA West LM Rouwe B etal | 2002 | CanccrRes2002，62，12： | 1 |
| 20 | Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole impet hemocyanin 显示文摘 | Krug LM Ragupathi G Hood C Kris MG Miller VA Allen JR | 2004 | Clin Cancer Res2004，10，18： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员